Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.26
0.23 (1.77%)
At close: Aug 15, 2025, 3:00 PM

Medifast Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
3.64M -7M 2.09M 7.33M 29.33M 67.76M 99.42M 119.9M 132.92M 141.75M 143.57M 151.07M 156.9M 164.75M 164.03M 158M 150.47M 125.44M
Depreciation & Amortization
13.7M 12.73M 13.81M 13.98M 14.2M 14.5M 13.11M 12.71M 12.15M 11.51M 10.98M 7.56M 7.35M 7.24M 6.81M 9.29M 8.43M 7.62M
Stock-Based Compensation
7.29M 7.12M 7.36M 7.62M 9.69M 9.75M 8.19M 8.74M 9.03M 9.38M 11.05M 11.39M 10.7M 9.98M 9.9M 9.17M 9.02M 8.01M
Other Working Capital
8.96M 11.71M 13.08M -8.13M -15.34M -24.02M -8.28M -7.15M -4.01M -25.73M -39.54M -23.38M -22.61M 14.61M 9.31M 1.85M 4.72M 2.23M
Other Non-Cash Items
1.46M 25.36M 42.29M 42.27M 40.43M 19.36M 4.84M 7.02M 10.74M 9.6M 9.86M 11.46M 6.74M 6.76M 5.16M 359K 955K 1.02M
Deferred Income Tax
-7.41M -7.5M -7.4M 6.82M 420K 1.14M 1.83M -4.06M -2.72M -1.74M -924K -5.46M -504K -2.1M -3.71M 1.34M 1.36M 564K
Change in Working Capital
-14.53M -4.68M -9.74M -14.14M -9.33M -3.13M 20.28M 44.56M 52.21M 44.45M 21.65M -39.04M -83.79M -112.13M -87.65M -56.32M -23.1M 41.12M
Operating Cash Flow
4.15M 20.6M 24.48M 39.95M 60.8M 90.88M 147.66M 188.87M 214.34M 214.96M 194.57M 135.37M 95.78M 72.89M 94.55M 121.83M 147.15M 183.79M
Capital Expenditures
-6.58M -7.13M -7.45M -6.12M -6.4M -6.21M -6.48M -14.6M -14.69M -15.79M -16.68M -19.24M -27.86M -32.62M -34.21M -24.62M -17.5M -10.19M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-60.01M -52.42M -46.59M -34.14M -72.21M -63.73M -54.56M -44.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
56.59M 33.66M 27.45M 22.35M 16.12M 8.23M n/a n/a n/a 4.02M 5.27M 5.27M 5.27M 2.67M 5.14M 7.75M 8.75M 7.33M
Other Investing Acitivies
89K -505K -1.45M -11.23M -56.09M -55.5M -54.56M -44.78M n/a 4.02M 5.27M 5.27M 5.27M 2.67M 5.14M 7.75M 8.75M 7.33M
Investing Cash Flow
-9.91M -25.8M -26.52M -17.82M -62.49M -61.71M -61.05M -59.38M -14.69M -11.77M -11.41M -13.97M -22.59M -29.95M -29.06M -16.87M -8.75M -2.87M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a 27M 27M 27M 27M n/a n/a n/a n/a n/a
Common Stock Repurchased
-373K -388K -836K -845K -953K -939K -6.96M -13.36M -13.27M -123.34M -127.96M -135.77M -162.05M -64.24M -62.09M -47.89M -21.62M -14.37M
Dividend Paid
-196K -199K -715K -18.69M -36.73M -54.56M -73.02M -72.96M -73M -74.12M -71.62M -70.71M -69.38M -67.12M -63.86M -60.14M -56.72M -53.33M
Other Financial Acitivies
-369K -369K 36K 119K 119K 119K 188K 105K -26.89M -26.89M -27M -27M 109K 330K 811K 984K 1.05M 2.08M
Financial Cash Flow
-569K -587K -1.51M -19.42M -37.57M -55.38M -79.79M -86.22M -113.17M -197.36M -199.58M -206.48M -204.32M -131.03M -125.13M -107.05M -77.29M -65.62M
Net Cash Flow
-6.32M -5.75M -3.51M 2.56M -39.39M -26.28M 6.75M 43.04M 86.34M 5.75M -16.49M -84.81M -130.92M -88.03M -59.54M -1.97M 61.16M 115.36M
Free Cash Flow
-2.42M 13.46M 17.02M 33.83M 54.4M 84.67M 141.17M 174.27M 199.65M 199.17M 177.89M 116.13M 67.91M 40.27M 60.34M 97.21M 129.65M 173.6M